Cerence Inc. CRNC · NASDAQ
$8.93 -2.62% (-$0.24)
Summary
42 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 25 USD is left as free cash.
- It beat profit estimates 7 times in the last 8 quarters.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 8.4% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 5.3% a year over 5 years. Over the last 3 years it fell by 8.4% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $15.4M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 10
- Sell 0
Today's price within the analysts' price targets
The average target of $23.38 is 162% above today's price. 23% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- License 56%
- Professional Services 23%
- Connected Services 21%
By region
- GERMANY 31%
- Other Asia Pacific 27%
- UNITED STATES 15%
- JAPAN 15%
- Other Europe Middle East And Africa 11%
- Other 0.5%
License brings in 56% of revenue.
Segments in detail